Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joep Perk

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
European Journal of Preventive Cardiology|October 7, 2016
An evaluation of the performance of SCORE Sweden 2015 in estimating cardiovascular risk: The Northern Sweden MONICA Study 1999-2014Tina Karjalainen, Martin Adiels, Lena Björck, et al.
BMC Cardiovascular Disorders|December 17, 2021
Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effectsKari Peersen, John Munkhaugen, Elise Sverre, et al.
Journal of Internal Medicine|February 1, 2022
Tailored clinical management after blinded statin challenge improved the lipid control in coronary patients with self-perceived muscle side effectsElise Sverre, Kari Peersen, Oscar Kristiansen, et al.
Scandinavian Cardiovascular Journal : SCJ|October 22, 2015
The role of medical and psychosocial factors for unfavourable coronary risk factor controlJohn Munkhaugen, Elise Sverre, Kari Peersen, et al.
European Journal of Preventive Cardiology|February 16, 2017
Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patientsJohn Munkhaugen, Elise Sverre, Jan E Otterstad, et al.
Journal of the American Society of Hypertension : JASH|November 13, 2017
Optimal blood pressure control after coronary events: the challenge remainsElise Sverre, Kari Peersen, Jan Erik Otterstad, et al.
European Journal of Preventive Cardiology|February 21, 2021
Optimising implementation of European guidelines on cardiovascular disease prevention in clinical practice: what is needed?Izabella Uchmanowicz, Arno Hoes, Joep Perk, et al.
Scandinavian Cardiovascular Journal : SCJ|April 30, 2019
Statin-associated muscle symptoms in coronary patients: design of a randomized studyJohn Munkhaugen, Nils Tore Vethe, Morten Wang Fagerland, et al.
Atherosclerosis|October 5, 2021
The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart diseaseOscar Kristiansen, Elise Sverre, Kari Peersen, et al.
BMC Cardiovascular Disorders|June 19, 2017
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational studyJulian P Halcox, José R Banegas, Carine Roy, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Preventive Cardiology|October 7, 2016
An evaluation of the performance of SCORE Sweden 2015 in estimating cardiovascular risk: The Northern Sweden MONICA Study 1999-2014Tina Karjalainen, Martin Adiels, Lena Björck, et al.
BMC Cardiovascular Disorders|December 17, 2021
Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effectsKari Peersen, John Munkhaugen, Elise Sverre, et al.
Journal of Internal Medicine|February 1, 2022
Tailored clinical management after blinded statin challenge improved the lipid control in coronary patients with self-perceived muscle side effectsElise Sverre, Kari Peersen, Oscar Kristiansen, et al.
Scandinavian Cardiovascular Journal : SCJ|October 22, 2015
The role of medical and psychosocial factors for unfavourable coronary risk factor controlJohn Munkhaugen, Elise Sverre, Kari Peersen, et al.
European Journal of Preventive Cardiology|February 16, 2017
Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patientsJohn Munkhaugen, Elise Sverre, Jan E Otterstad, et al.
Journal of the American Society of Hypertension : JASH|November 13, 2017
Optimal blood pressure control after coronary events: the challenge remainsElise Sverre, Kari Peersen, Jan Erik Otterstad, et al.
European Journal of Preventive Cardiology|February 21, 2021
Optimising implementation of European guidelines on cardiovascular disease prevention in clinical practice: what is needed?Izabella Uchmanowicz, Arno Hoes, Joep Perk, et al.
Scandinavian Cardiovascular Journal : SCJ|April 30, 2019
Statin-associated muscle symptoms in coronary patients: design of a randomized studyJohn Munkhaugen, Nils Tore Vethe, Morten Wang Fagerland, et al.
Atherosclerosis|October 5, 2021
The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart diseaseOscar Kristiansen, Elise Sverre, Kari Peersen, et al.
BMC Cardiovascular Disorders|June 19, 2017
Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational studyJulian P Halcox, José R Banegas, Carine Roy, et al.
Pageof 9